Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net sales	$ 3,170	$ 2,932	$ 9,440	$ 8,761
Cost of products sold	979	900	2,945	2,739
Gross profit	2,191	2,032	6,495	6,022
Operating expenses:
Selling, general and administrative expenses	1,132	1,066	3,357	3,206
Research and development expenses	339	310	993	884
Royalty expense	11	14	34	38
Amortization expense	202	184	604	549
Intangible asset impairment charges	125	128	132	173
Contingent consideration net expense (benefit)	20	(26)	68	(117)
Restructuring net charges (credits)	4	9	18	18
Litigation-related net charges (credits)	0	0	42	302
Gain on disposal of businesses and assets	0	(40)	0	(48)
Operating expenses	1,833	1,645	5,248	5,003
Operating income (loss)	358	387	1,247	1,019
Other income (expense):
Interest expense	(63)	(86)	(406)	(254)
Other, net	(51)	181	(96)	192
Income (loss) before income taxes	245	483	745	957
Income tax expense (benefit)	57	64	188	10
Net income (loss)	188	419	558	946
Preferred stock dividends	(14)	(14)	(42)	(42)
Net income (loss) available to common stockholders	$ 174	$ 405	$ 516	$ 905
Net income (loss) per common share — basic	$ 0.12	$ 0.28	$ 0.36	$ 0.64
Net income (loss) per common share — assuming dilution	$ 0.12	$ 0.28	$ 0.36	$ 0.63
Weighted-average shares outstanding
Basic	1,431.6	1,423.8	1,429.7	1,421.3
Assuming dilution	1,440.0	1,435.6	1,438.7	1,433.0